Product Defect

Metformin Carcinogenic Contaminants Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating manufacturers of the widely used diabetes drug metformin, known by the common brand names Glucofage, Riomet, and Glumetza, for product contamination. Online pharmacy Valisure tested various metformin batches for impurities containing N-nitrosodimethylamine, or NDMA, a probable human carcinogen, and found sixteen contaminated batches. One batch contained sixteen times […]

Product Defect

Ranitidine Carcinogenic Contaminants Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating manufacturers of the prescription and over-the-counter heartburn medication ranitidine, known by the brand name Zantac. The U.S. Food and Drug Administration (FDA) recently requested manufacturers pull the drug from the market, citing an ongoing investigation that found many ranitidine samples contained hazardous levels of the contaminant NDMA, a […]

Product Defect

BD Alaris System Infusion Pump Recall

Posted on

Migliaccio & Rathod LLP is currently investigating the recent FDA Class I recall of Becton Dickinson Alaris system infusion pumps due to multiple system errors, software errors, and use-related errors. These infusion pumps continuously or intermittently deliver fluids, medications, blood and blood products to adult, pediatric, or neonatal patients in large volumes. The errors experienced […]

Consumer Protection

Pharmacy Chain Prescription Error

Posted on

Migliaccio & Rathod LLP is currently investigating pharmacy chains such as CVS Health and Walgreens Co. for endangerment of patient safety due to systemic understaffing and unreasonable performance metrics. Pharmacy chains dispense approximately 70% of prescriptions nationwide, with billions filled each year. Yet overworked pharmacists fear their chaotic work conditions expose patients to the possibility […]